Trinity Biotech (TRIB) Share-based Compensation (2009 - 2024)
Trinity Biotech (TRIB) posted quarterly Share-based Compensation of $140000.0 for Q4 2024, up 113.88% year-on-year from $65458.8 in Q1 2024, and up 55900.0% on a QoQ basis from $250.0 in Q3 2024.
Trinity Biotech (TRIB) Share-based Compensation (2009 - 2024) Analysis & Trends
Trinity Biotech (TRIB) has reported Share-based Compensation for 11 consecutive years, with $140000.0 the latest figure, recorded in Q4 2024.
- Quarterly Share-based Compensation rose 113.88% year-over-year to $140000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $141176.0 (up 114.03% YoY) and the FY2025 annual result came in at $324000.0, down 75.38% from the prior year.
- Share-based Compensation climbed to $140000.0 in Q4 2024 per TRIB's latest filing, from $250.0 in the prior quarter.
- Over the last five years, Share-based Compensation for TRIB reached as high as $1.3 million in Q4 2022 and fell as low as -$1.0 million in Q4 2023.
- A 4-year average of $55899.0 and a median of $812.0 in 2024 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 755.84% — and 2023, when it plunged 176.56%.
- Year by year, Share-based Compensation stood at $154000.0 in 2021, then surged by 755.84% to $1.3 million in 2022, then tumbled by 176.56% to -$1.0 million in 2023, then soared by 113.88% to $140000.0 in 2024.
- According to Business Quant data, Share-based Compensation over the past three periods registered $140000.0, $250.0, and $114.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 140,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 250.00 |
| Sep 30, 2024 | 250.00 |
| Jun 30, 2024 | 114.00 |
| Jun 30, 2024 | 114.00 |
| Mar 31, 2024 | 812.00 |
| Mar 31, 2024 | 812.00 |
| Dec 31, 2023 | -1.01 Mn |
| Dec 31, 2023 | -1.01 Mn |
| Sep 30, 2023 | 738.00 |
| Sep 30, 2023 | 738.00 |
| Jun 30, 2023 | 975.00 |
| Jun 30, 2023 | 975.00 |
| Mar 31, 2023 | 1,364.00 |
| Mar 31, 2023 | 1,364.00 |
| Dec 31, 2022 | 1.32 Mn |
| Dec 31, 2022 | 1.32 Mn |
| Sep 30, 2022 | 119,000.00 |
| Sep 30, 2022 | 119,000.00 |